The Apoprotein E4 isotype does not affect the severity of COVID-19 infection and other flu-like syndromes.

Marina Carvalho-Rassbach, Lucas Haniel Araujo Ventura, Larissa Oliveira Assis, Sabrina Fabrini, Manuelle Maria Pereira Natividade, Janayne Luihan Silva, Karina Braga Gomes, Ana Maria Caetano Faria, Jacqueline I Alvarez-Leite
{"title":"The Apoprotein E4 isotype does not affect the severity of COVID-19 infection and other flu-like syndromes.","authors":"Marina Carvalho-Rassbach, Lucas Haniel Araujo Ventura, Larissa Oliveira Assis, Sabrina Fabrini, Manuelle Maria Pereira Natividade, Janayne Luihan Silva, Karina Braga Gomes, Ana Maria Caetano Faria, Jacqueline I Alvarez-Leite","doi":"10.1099/jmm.0.001951","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> Apolipoprotein E (ApoE), especially the ApoE4 isotype, is suggested to influence the severity of respiratory viral infections; however, this association is still unclear.<b>Hypothesis.</b> The presence of allele ε4 impacts the development of flu-like syndromes.<b>Aim.</b> This study aimed to evaluate the impact of the Apo E4 isoform on the severity and duration of flu-like syndromes, including the coronavirus disease COVID-19.<b>Methodology.</b> This study comprised 280 individuals presenting flu-like symptoms, all genotyped for ApoE isoforms. Data were collected on clinical course, comorbidities, nutritional status, biochemical and inflammatory markers, SARS-CoV-2 reverse transcription PCR results and disease severity (mild, moderate or severe) according to the World Health Organization criteria. The individuals were analysed as a whole and within subgroups based on the SARS-CoV-2-positive (COVID-19 group) or SARS-CoV-2-negative (flu-like syndrome group) test.<b>Results.</b> The frequency of the ε4 allele was similar across the whole population and in both the COVID-19 and flu-like syndrome subgroups (17 and 18%, respectively). No differences were seen in sex, age range, self-reported skin colour, body mass index (BMI), number of comorbidities, vaccination status, biochemical, cytokine and lipid profiles (except for total cholesterol) in the flu-like group when ε4 allele carriers and non-carriers were compared. In the COVID-19 group, the ε4 allele did not correlate with disease severity or duration, number of comorbidities or inflammatory biomarkers. While gender distribution was equal in the overall COVID-19 population, male gender strongly correlated with COVID-19 severity. Multivariate analysis showed that older individuals, male gender, higher BMI and the presence of comorbidities were linked to increased chances of developing moderate and severe disease. IL-4 was the only factor found to reduce the risk of severe COVID-19.<b>Conclusion.</b> The presence of one ɛ4 allele showed no association with the duration and severity of flu-like syndromes, including COVID-19. Nonetheless, SARS-CoV-2-positive individuals tend to be older men with a higher BMI and a tendency to be overweight or with obesity. Regarding COVID-19 severity, BMI, male sex and the number of associated comorbidities were the factors that increased the chance of developing a more severe form of COVID-19.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"74 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/jmm.0.001951","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Apolipoprotein E (ApoE), especially the ApoE4 isotype, is suggested to influence the severity of respiratory viral infections; however, this association is still unclear.Hypothesis. The presence of allele ε4 impacts the development of flu-like syndromes.Aim. This study aimed to evaluate the impact of the Apo E4 isoform on the severity and duration of flu-like syndromes, including the coronavirus disease COVID-19.Methodology. This study comprised 280 individuals presenting flu-like symptoms, all genotyped for ApoE isoforms. Data were collected on clinical course, comorbidities, nutritional status, biochemical and inflammatory markers, SARS-CoV-2 reverse transcription PCR results and disease severity (mild, moderate or severe) according to the World Health Organization criteria. The individuals were analysed as a whole and within subgroups based on the SARS-CoV-2-positive (COVID-19 group) or SARS-CoV-2-negative (flu-like syndrome group) test.Results. The frequency of the ε4 allele was similar across the whole population and in both the COVID-19 and flu-like syndrome subgroups (17 and 18%, respectively). No differences were seen in sex, age range, self-reported skin colour, body mass index (BMI), number of comorbidities, vaccination status, biochemical, cytokine and lipid profiles (except for total cholesterol) in the flu-like group when ε4 allele carriers and non-carriers were compared. In the COVID-19 group, the ε4 allele did not correlate with disease severity or duration, number of comorbidities or inflammatory biomarkers. While gender distribution was equal in the overall COVID-19 population, male gender strongly correlated with COVID-19 severity. Multivariate analysis showed that older individuals, male gender, higher BMI and the presence of comorbidities were linked to increased chances of developing moderate and severe disease. IL-4 was the only factor found to reduce the risk of severe COVID-19.Conclusion. The presence of one ɛ4 allele showed no association with the duration and severity of flu-like syndromes, including COVID-19. Nonetheless, SARS-CoV-2-positive individuals tend to be older men with a higher BMI and a tendency to be overweight or with obesity. Regarding COVID-19 severity, BMI, male sex and the number of associated comorbidities were the factors that increased the chance of developing a more severe form of COVID-19.

载脂蛋白E4同型不影响COVID-19感染和其他流感样综合征的严重程度。
介绍。载脂蛋白E (ApoE),特别是ApoE4同型,被认为影响呼吸道病毒感染的严重程度;然而,这种联系仍然不清楚。等位基因ε4的存在影响流感样综合征的发展。本研究旨在评估载脂蛋白E4亚型对流感样综合征(包括冠状病毒covid -19)严重程度和持续时间的影响。这项研究包括280名出现流感样症状的个体,所有人都有ApoE亚型基因分型。根据世界卫生组织的标准收集临床病程、合并症、营养状况、生化和炎症标志物、SARS-CoV-2反转录PCR结果和疾病严重程度(轻度、中度或重度)的数据。根据sars - cov -2阳性(COVID-19组)或sars - cov -2阴性(流感样综合征组)检测对个体进行整体和亚组分析。在整个人群中,以及在COVID-19和流感样综合征亚组中,ε4等位基因的频率相似(分别为17%和18%)。当比较ε4等位基因携带者和非携带者时,流感样组在性别、年龄范围、自我报告的肤色、体重指数(BMI)、合并症数量、疫苗接种状况、生化、细胞因子和脂质谱(总胆固醇除外)方面没有发现差异。在COVID-19组中,ε4等位基因与疾病严重程度或持续时间、合共病数量或炎症生物标志物无关。虽然COVID-19总体人群的性别分布是平等的,但男性性别与COVID-19严重程度密切相关。多变量分析表明,年龄较大的个体、男性、较高的身体质量指数和合并症的存在与发展为中度和重度疾病的机会增加有关。IL-4是唯一能降低严重covid -19风险的因素。1个等位基因的存在与流感样综合征(包括COVID-19)的持续时间和严重程度无关。尽管如此,sars - cov -2阳性个体往往是体重指数较高的老年男性,并且有超重或肥胖的倾向。就COVID-19的严重程度而言,BMI、男性性别和相关合并症的数量是增加发生更严重形式的COVID-19的机会的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信